X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
breast cancer (8) 8
ovarian cancer (7) 7
mutation (6) 6
brca1 protein (5) 5
cancer (5) 5
oncology (5) 5
gene mutations (4) 4
genetic aspects (4) 4
index medicus (4) 4
genes (3) 3
germline mutations (3) 3
health risks (3) 3
humans (3) 3
p53 protein (3) 3
risk (3) 3
adult (2) 2
aged (2) 2
apoptosis (2) 2
blood (2) 2
brca2 protein (2) 2
breast (2) 2
carriers (2) 2
chemotherapy (2) 2
clonal hematopoiesis (2) 2
consortia (2) 2
deoxyribonucleic acid--dna (2) 2
estrogen receptors (2) 2
female (2) 2
genetic association studies (2) 2
genetic predisposition to disease (2) 2
genetic variation (2) 2
health risk assessment (2) 2
middle aged (2) 2
ppm1d (2) 2
research (2) 2
research article (2) 2
skin and connective tissue diseases (2) 2
tp53 (2) 2
tumor proteins (2) 2
tumors (2) 2
women (2) 2
1-phosphatidylinositol 3-kinase (1) 1
3111 biomedicine (1) 1
acid (1) 1
adipose tissue (1) 1
age (1) 1
aged, 80 and over (1) 1
akt protein (1) 1
animals (1) 1
anthropometric measures (1) 1
association (1) 1
ataxia-telangiectasia (1) 1
autoimmunity (1) 1
bard1 (1) 1
biochemistry, genetics and molecular biology (1) 1
biomarkers, tumor (1) 1
biotechnology & applied microbiology (1) 1
body mass (1) 1
body mass index (1) 1
body size (1) 1
brca1 (1) 1
breast cancer predisposition (1) 1
breast neoplasms - genetics (1) 1
breast neoplasms - pathology (1) 1
brip1 gene (1) 1
cancer biology (1) 1
cancers (1) 1
case-control studies (1) 1
cell & tissue engineering (1) 1
cell biology (1) 1
cell cycle checkpoints (1) 1
cell proliferation (1) 1
cells (1) 1
chek2-asterisk-1100delc (1) 1
chemistry (1) 1
chromatin (1) 1
cohort (1) 1
complex (1) 1
confer susceptibility (1) 1
confidence intervals (1) 1
cyclin e2 (1) 1
developmental biology (1) 1
diagnosis (1) 1
differentiation (1) 1
disease (1) 1
dk/atira/pure/subjectarea/asjc/1300 (1) 1
dk/atira/pure/subjectarea/asjc/1600 (1) 1
dk/atira/pure/subjectarea/asjc/3100 (1) 1
dna methylation (1) 1
dna sequencing (1) 1
e-cadherin (1) 1
early onset breast cancer (1) 1
endurance (1) 1
enhancers (1) 1
epidermal growth factor (1) 1
erbb-2 protein (1) 1
estrogens (1) 1
etiology (1) 1
expression (1) 1
families (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Breast Cancer Research, ISSN 1465-5411, 01/2018, Volume 20, Issue 1, pp. 7 - 6
Journal Article
Human Mutation, ISSN 1059-7794, 12/2018, Volume 39, Issue 12, pp. 2040 - 2046
The Li‐Fraumeni cancer predisposition syndrome (LFS1) presents with a variety of tumor types and the TP53 gene is covered by most diagnostic cancer gene... 
clonal hematopoiesis | PPM1D | Li‐Fraumeni syndrome | chemotherapy | TP53 | Chemotherapy | Genetic aspects | Diagnosis | Gene mutations | Tumor proteins | Cancer | Mutation | p53 Protein | Deoxyribonucleic acid--DNA | Ovarian cancer | Hemopoiesis
Journal Article
BREAST CANCER RESEARCH, ISSN 1465-542X, 04/2019, Volume 21, Issue 1, p. 55
BackgroundThe role of the BARD1 gene in breast cancer (BC) and ovarian cancer (OC) predisposition remains elusive, as published case-control investigations... 
BARD1 | PROTEIN | ONCOLOGY | Germline mutations | Early onset breast cancer | MUTATIONS | BRCA1 | Ovarian cancer | Genetic aspects | Breast cancer | Research | Gene mutations | Genetic variation
Journal Article
by Qian, F and Rookus, MA and Leslie, G and Risch, HA and Greene, MH and Aalfs, CM and Adank, MA and Adlard, J and Agnarsson, BA and Ahmed, M and Aittomaki, K and Andrulis, IL and Arnold, N and Arun, BK and Ausems, MGEM and Azzollini, J and Barrowdale, D and Barwell, J and Benitez, J and Bialkowska, K and Bonadona, V and Borde, J and Borg, A and Bradbury, AR and Brunet, J and Buys, SS and Caldes, T and Caligo, MA and Campbell, I and Carter, J and Chiquette, J and Chung, WK and Claes, KBM and Collee, JM and Collonge-Rame, MA and Couch, FJ and Daly, MB and Delnatte, C and Diez, O and Domchek, SM and Dorfling, CM and Eason, J and Easton, DF and Eeles, R and Engel, C and Evans, DG and Faivre, L and Feliubado, L and Foretova, L and Friedman, E and Frost, D and Ganz, PA and Garber, J and Garcia-Barberan, V and Gehrig, A and Glendon, G and Godwin, AK and Garcia, EBG and Hamann, U and Hauke, J and Hopper, JL and Hulick, PJ and Imyanitov, EN and Isaacs, C and Izatt, L and Jakubowska, A and Janavicius, R and John, EM and Karlan, BY and Kets, CM and Laitman, Y and Lazaro, C and Leroux, D and Lester, J and Lesueur, F and Loud, JT and Lubinski, J and Lukomska, A and McGuffog, L and Mebirouk, N and Meijers-Heijboer, HEJ and Meindl, A and Miller, A and Montagna, M and Mooij, TM and Mouret-Fourme, E and Nathanson, KL and Nehoray, B and Neuhausen, SL and Nevanlinna, H and Nielsen, FC and Offit, K and Olah, E and Ong, KR and Oosterwijk, JC and Ottini, L and Parsons, MT and Peterlongo, P and Pfeiler, G and Pradhan, N and ... and KConFab Investigators and HEBON Investigators and GEMO Study Collaborators and CIMBA and EMBRACE Collaborators and on behalf of CIMBA
BRITISH JOURNAL OF CANCER, ISSN 0007-0920, 07/2019, Volume 121, Issue 2, pp. 180 - 192
BACKGROUND: Height and body mass index (BMI) are associated with higher ovarian cancer risk in the general population, but whether such associations exist... 
MORTALITY | PATHWAYS | APOPTOSIS | OBESITY | ONCOLOGY | INFERTILITY | ANTHROPOMETRIC MEASURES | COHORT | PROGESTIN | ASSOCIATION | BREAST | BRCA2 protein | Ovarian carcinoma | BRCA1 protein | Health risks | Risk | Breast cancer | Ovarian cancer | Post-menopause | Carriers | Consortia | Confidence intervals | Body mass index | Randomization | Body mass | Body size | Hormone replacement therapy | Mutation | Health risk assessment | Cancer
Journal Article
by Ferreira, Manuel A and Gamazon, Eric R and Al-Ejeh, Fares and Aittomäki, Kristiina and Andrulis, Irene L and Anton-Culver, Hoda and Arason, Adalgeir and Arndt, Volker and Aronson, Kristan J and Arun, Banu K and Asseryanis, Ella and Azzollini, Jacopo and Balmaña, Judith and Barnes, Daniel R and Barrowdale, Daniel and Beckmann, Matthias W and Behrens, Sabine and Benitez, Javier and Bermisheva, Marina and Białkowska, Katarzyna and Blomqvist, Carl and Bogdanova, Natalia V and Bojesen, Stig E and Bolla, Manjeet K and Borg, Ake and Brauch, Hiltrud and Brenner, Hermann and Broeks, Annegien and Burwinkel, Barbara and Caldés, Trinidad and Caligo, Maria A and Campa, Daniele and Campbell, Ian and Canzian, Federico and Carter, Jonathan and Carter, Brian D and Castelao, Jose E and Chang-Claude, Jenny and Chanock, Stephen J and Christiansen, Hans and Chung, Wendy K and Claes, Kathleen B. M and Clarke, Christine L and Adlard, Julian and Ahmed, Munaza and Barwell, Julian and Brady, Angela and Brewer, Carole and Cook, Jackie and Davidson, Rosemarie and Donaldson, Alan and Eason, Jacqueline and Eeles, Ros and Evans, D. Gareth and Gregory, Helen and Hanson, Helen and Henderson, Alex and Hodgson, Shirley and Izatt, Louise and Kennedy, M. John and Lalloo, Fiona and Miller, Clare and Morrison, Patrick J and Ong, Kai-ren and Perkins, Jo and Porteous, Mary E and Rogers, Mark T and Side, Lucy E and Snape, Katie and Walker, Lisa and Harrington, Patricia A and Arnold, Norbert and Auber, Bernd and Bogdanova-Markov, Nadja and Borde, Julika and Caliebe, Almuth and Ditsch, Nina and Dworniczak, Bernd and Engert, Stefanie and Faust, Ulrike and Gehrig, Andrea and Hahnen, Eric and Hauke, Jan and Hentschel, Julia and Herold, Natalie and Honisch, Ellen and Just, Walter and Kast, Karin and Larsen, Mirjam and Lemke, Johannes and Nguyen, Huu Phuc and Niederacher, Dieter and Ott, Claus-Eric and Platzer, Konrad and Pohl-Rescigno, Esther and Ramser, Juliane and Rhiem, Kerstin and Steinemann, Doris and Sutter, Christian and Varon-Mateeva, Raymonda and ... and BCFR Investigators and ABCTB Investigators and HEBON Investigators and GC-HBOC Study Collaborators and GEMO Study Collaborators and EMBRACE Collaborators
Nature Communications, ISSN 2041-1723, 12/2019, Volume 10, Issue 1, pp. 1741 - 18
Genome-wide association studies (GWAS) have identified more than 170 breast cancer susceptibility loci. Here we hypothesize that some risk-associated variants... 
REGULATOR | CELLS | COMPLEX | VARIANTS | CHROMATIN | CYCLIN E2 | AUTOIMMUNITY | MULTIDISCIPLINARY SCIENCES | DISEASE | ENHANCERS | EXPRESSION | Spleen | Immune response | Adipose tissue | Target recognition | Genes | Estrogens | Health risks | Estrogen receptors | Risk | Breast cancer | Genomes | Gene expression | Loci | Quantitative trait loci | Etiology | Breast | Gene mapping | Health risk assessment | Cancer | Immune system
Journal Article
Human Mutation, ISSN 1059-7794, 12/2018, Volume 39, Issue 12, pp. 2040 - 2046
The Li-Fraumeni cancer predisposition syndrome (LFS1) presents with a variety of tumor types and the TP53 gene is covered by most diagnostic cancer gene... 
clonal hematopoiesis | PPM1D | chemotherapy | TP53 | Li-Fraumeni syndrome | CANCERS | GENETICS & HEREDITY | FRAMEWORK | BLOOD
Journal Article
Stem Cell Research, ISSN 1873-5061, 05/2014, Volume 12, Issue 3, pp. 742 - 753
Journal Article
Cancer Medicine, ISSN 2045-7634, 04/2018, Volume 7, Issue 4, pp. 1349 - 1358
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.